Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Osage University Partners has thrown its weight behind a series A2 round for Artizan, which is advancing work undertaken at Yale University.

Xenotransplantation technology developer eGenesis has raised $125m in a series C round backed by Osage University Partners.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Karolinska Development has named Per Aniansson has its chief financial officer and investment director to replace Fredrik Järrsten.

Oxford Sciences Innovation has returned to back a $30m funding round for Genomics, having previously contributed to a 2018 series B round.

IP Group and V-Bio have backed a round that will support phase 2 trials for a treatment for diabetic macular edema.

The vehicle will invest in all winners of the Venture Kick competition and will provide follow-on funding in two subsequent rounds.

Carisma Therapeutics has increased its series B round to $59m thanks to an extension backed by IP Group, Penn Medicine and 4Bio Capital.

RTW Investments has a series C for the UT Southwestern and Gladstone Institutes spinout, which will progress its lead asset into the clinic.